JN AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 102: 2554-2562, 2009. First published August 19, 2009; doi:10.1152/jn.00480.2009
0022-3077/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
102/4/2554    most recent
00480.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Wehr, M.
Right arrow Articles by Kentros, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wehr, M.
Right arrow Articles by Kentros, C.

INNOVATIVE METHODOLOGY

Transgenic Silencing of Neurons in the Mammalian Brain by Expression of the Allatostatin Receptor (AlstR)

M. Wehr1,2, U. Hostick, M. Kyweriga2,3, A. Tan2, A. P. Weible2, H. Wu2, W. Wu5, E. M. Callaway6 and C. Kentros1,2

1Departments of Psychology and 3Biology, 2Institute of Neuroscience, and 4Transgenic Mouse Facility, University of Oregon, Eugene, Oregon; 5Oregon Health and Sciences University, Portland, Oregon; and 6The Salk Institute for Biological Studies, La Jolla, California

Submitted 4 June 2009; accepted in final form 13 August 2009

ABSTRACT

The mammalian brain is an enormously complex set of circuits composed of interconnected neuronal cell types. The analysis of central neural circuits will be greatly served by the ability to turn off specific neuronal cell types while recording from others in intact brains. Because drug delivery cannot be restricted to specific cell types, this can only be achieved by putting "silencer" transgenes under the control of neuron-specific promoters. Towards this end we have created a line of transgenic mice putting the Drosophila allatostatin (AL) neuropeptide receptor (AlstR) under the control of the tetO element, thus enabling its inducible expression when crossed to tet-transactivator lines. Mammals have no endogenous AL or AlstR, but activation of exogenously expressed AlstR in mammalian neurons leads to membrane hyperpolarization via endogenous G-protein-coupled inward rectifier K+ channels, making the neurons much less likely to fire action potentials. Here we show that this tetO/AlstR line is capable of broadly expressing AlstR mRNA in principal neurons throughout the forebrain when crossed to a commercially-available transactivator line. We electrophysiologically characterize this cross in hippocampal slices, demonstrating that bath application of AL leads to hyperpolarization of CA1 pyramidal neurons, making them refractory to the induction of action potentials by injected current. Finally, we demonstrate the ability of AL application to silence the sound-evoked spiking responses of auditory cortical neurons in intact brains of AlstR/tetO transgenic mice. When crossed to other transactivator lines expressing in defined neuronal cell types, this AlstR/tetO line should prove a very useful tool for the analysis of intact central neural circuits.


Address for reprint requests and other correspondence: C. Kentros, Dept of Psychology, University of Oregon, Eugene, OR 97403 (E-mail: cliff{at}uoneuro.uoregon.edu).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the The American Physiological Society.